Advanced search for publications
Enter your keywords
Ciclosporin eye drops for dry eye disease
This document compares the ciclosporin eye drops licensed in the UK for use in adults. It is intended as a quick reference to summarise differences between the available preparations.
Formulary assessment – Ciclosporin 0.9 mg/ml eye drops (Cequa)
Formulary assessment tools are templates to support local decision making. They list NICE guidance, MHRA safety advice, and other relevant high quality advice and guidelines relevant to making decisions for local formularies. The templates are pre-populated with useful information to reduce duplication of effort, with space for the addition of local information as appropriate. The […]
Brolucizumab for wet age-related macular degeneration
Brolucizumab is a monoclonal antibody specific for vascular endothelial growth factor (VEGF). It is indicated for treatment of wet age-related macular degeneration (AMD), and is administered as an intravitreal injection every eight or 12 weeks. Download the full review below to read more.